☰

Dezheng Huo, Ph.D. - Publications

Affiliations: 
2005 University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Public Health
Tree Info Similar researchers PubMed Report error

249 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ochs-Balcom HM, Preus L, Du Z, Elston RC, Teerlink CC, Jia G, Guo X, Cai Q, Long J, Ping J, Li B, Stram DO, Shu XO, Sanderson M, Gao G, ... ... Huo D, et al. Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia. Human Molecular Genetics. PMID 38263910 DOI: 10.1093/hmg/ddae002  0.348
2024 Omoleye OJ, Freeman JQ, Oluwasanu M, Adeniji-Sofoluwe A, Woodard AE, Aribisala BS, Adejumo PO, Ntekim A, Makumbi T, Ndom P, Ajayi IO, Olopade OI, Huo D. Benign breast disease and breast cancer risk in African women: a case-control study. Cancer Causes & Control : Ccc. PMID 38177455 DOI: 10.1007/s10552-023-01837-1  0.367
2024 Zirpoli GR, Pfeiffer RM, Bertrand KA, Huo D, Lunetta KL, Palmer JR. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Research : Bcr. 26: 2. PMID 38167144 DOI: 10.1186/s13058-023-01748-8  0.342
2023 Vannier AGL, Dhungana A, Zhao F, Chen N, Shubeck S, Hahn OM, Nanda R, Jaskowiak NT, Fleming GF, Olopade OI, Pearson AT, Huo D, Howard FM. Validation of the RSClin risk calculator in the National Cancer Data Base. Cancer. PMID 38146744 DOI: 10.1002/cncr.35163  0.311
2023 Omoleye OJ, Freeman JQ, Oluwasanu M, Adeniji-Sofoluwe A, Woodard AE, Aribisala BS, Adejumo PO, Ntekim A, Makumbi T, Ndom P, Ajayi IO, Olopade OI, Huo D. Benign breast disease and breast cancer risk in African women: A case-control study. Research Square. PMID 37693385 DOI: 10.21203/rs.3.rs-3301977/v1  0.358
2023 Freeman JQ, Khwaja A, Zhao F, Nanda R, Olopade OI, Huo D. Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. PMID 37676974 DOI: 10.1089/tmj.2023.0225  0.309
2023 Howard FM, Peiffer DS, Huo D. Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores-Reply. Jama Oncology. PMID 37498624 DOI: 10.1001/jamaoncol.2023.2638  0.348
2023 Freeman JQ, Sheade J, Zhao F, Olopade OI, Nanda R, Huo D. Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer. Integrative Cancer Therapies. 22: 15347354231185122. PMID 37462224 DOI: 10.1177/15347354231185122  0.331
2023 Miyashita M, Bell JSK, Wenric S, Karaesmen E, Rhead B, Kase M, Kaneva K, De La Vega FM, Zheng Y, Yoshimatsu TF, Khramtsova G, Liu F, Zhao F, Howard FM, Nanda R, ... ... Huo D, et al. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations. Breast Cancer Research : Bcr. 25: 58. PMID 37231433 DOI: 10.1186/s13058-023-01627-2  0.342
2023 Gao G, Fiorica PN, McClellan J, Barbeira AN, Li JL, Olopade OI, Im HK, Huo D. A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes. American Journal of Human Genetics. PMID 37164006 DOI: 10.1016/j.ajhg.2023.04.005  0.341
2023 Freeman JQ, Shubeck S, Howard FM, Chen N, Nanda R, Huo D. Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients. Npj Breast Cancer. 9: 33. PMID 37149628 DOI: 10.1038/s41523-023-00536-z  0.319
2023 Zhao F, Miyashita M, Hattori M, Yoshimatsu T, Howard F, Kaneva K, Jones R, Bell JSK, Fleming GF, Jaskowiak N, Nanda R, Zheng Y, Huo D, Olopade OI. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. Jama Network Open. 6: e233329. PMID 36995716 DOI: 10.1001/jamanetworkopen.2023.3329  0.337
2023 Shubeck S, Zhao F, Howard FM, Olopade OI, Huo D. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US. Jama Network Open. 6: e235834. PMID 36995711 DOI: 10.1001/jamanetworkopen.2023.5834  0.336
2023 Luo J, Kibriya MG, Chen H, Kim K, Ahsan H, Olopade OI, Olopade CS, Aschebrook-Kilfoy B, Huo D. A metabolome-wide case-control study of african american breast cancer patients. Bmc Cancer. 23: 183. PMID 36823587 DOI: 10.1186/s12885-023-10656-1  0.357
2023 Peiffer DS, Zhao F, Chen N, Hahn OM, Nanda R, Olopade OI, Huo D, Howard FM. Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database. Jama Oncology. PMID 36821125 DOI: 10.1001/jamaoncol.2022.7476  0.364
2023 Miyashita M, Balogun OB, Olopade OI, Huo D. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions. Scientific Reports. 13: 2880. PMID 36804591 DOI: 10.1038/s41598-023-29888-z  0.32
2022 Ashi K, Ndom P, Gakwaya A, Makumbi T, Olopade OI, Huo D. Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36215182 DOI: 10.1158/1055-9965.EPI-22-0869  0.364
2022 Han YJ, Zhang J, Hardeman A, Liu M, Karginova O, Romero R, Khramtsova GF, Zheng Y, Huo D, Olopade OI. An Enhancer Variant Associated with Breast Cancer Susceptibility in Black Women Regulates TNFSF10 Expression and Antitumor Immunity in Triple-Negative Breast Cancer. Human Molecular Genetics. PMID 35930348 DOI: 10.1093/hmg/ddac168  0.355
2022 Gao G, Zhao F, Ahearn TU, Lunetta KL, Troester MA, Du Z, Ogundiran TO, Ojengbede O, Blot W, Nathanson KL, Domchek SM, Nemesure B, Hennis A, Ambs S, McClellan J, ... ... Huo D, et al. Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach. Human Molecular Genetics. PMID 35554533 DOI: 10.1093/hmg/ddac102  0.355
2022 Pollock NC, Ramroop JR, Hampel H, Troester MA, Conway K, Hu JJ, Freudenheim JL, Olopade OI, Huo D, Ziv E, Neuhausen SL, Stevens P, McElroy JP, Toland AE. Differences in somatic TP53 mutation type in breast tumors by race and receptor status. Breast Cancer Research and Treatment. PMID 35286522 DOI: 10.1007/s10549-022-06509-3  0.313
2021 Vanderpuye V, Dadzie MA, Huo D, Olopade OI. Assessment of Breast Cancer Management in Sub-Saharan Africa. Jco Global Oncology. 7: 1593-1601. PMID 34843373 DOI: 10.1200/GO.21.00282  0.307
2021 Ansari-Pour N, Zheng Y, Yoshimatsu TF, Sanni A, Ajani M, Reynier JB, Tapinos A, Pitt JJ, Dentro S, Woodard A, Rajagopal PS, Fitzgerald D, Gruber AJ, Odetunde A, Popoola A, ... ... Huo D, et al. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nature Communications. 12: 6946. PMID 34836952 DOI: 10.1038/s41467-021-27079-w  0.324
2021 Adedokun B, Du Z, Gao G, Ahearn TU, Lunetta KL, Zirpoli G, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nature Communications. 12: 4198. PMID 34234117 DOI: 10.1038/s41467-021-24327-x  0.37
2021 Han Y, Lv J, Yu C, Guo Y, Bian Z, Hu Y, Yang L, Chen Y, Du H, Zhao F, Wen W, Shu XO, Xiang Y, Gao YT, Zheng W, ... ... Huo D, et al. Development and external validation of a breast cancer absolute risk prediction model in Chinese population. Breast Cancer Research : Bcr. 23: 62. PMID 34051827 DOI: 10.1186/s13058-021-01439-2  0.315
2021 Du Z, Gao G, Adedokun B, Ahearn T, Lunetta KL, Zirpoli G, Troester MA, Ruiz-Narváez EA, Haddad SA, Pal Choudhury P, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, ... ... Huo D, et al. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. Journal of the National Cancer Institute. PMID 33769540 DOI: 10.1093/jnci/djab050  0.331
2020 Zhao F, Copley B, Niu Q, Liu F, Johnson JA, Sutton T, Khramtsova G, Sveen E, Yoshimatsu TF, Zheng Y, Ibraheem A, Jaskowiak N, Nanda R, Fleming GF, Olopade OI, ... Huo D, et al. Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Research and Treatment. PMID 33111220 DOI: 10.1007/s10549-020-05984-w  0.349
2020 Qian F, Huo D. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-specific Cancers: Cohort Study Analyses from the UK Biobank. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32856611 DOI: 10.1158/1055-9965.Epi-20-0743  0.364
2020 Liu J, Prager-van der Smissen WJC, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, ... ... Huo D, et al. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. 10: 9688. PMID 32546843 DOI: 10.1038/S41598-020-65665-Y  0.499
2020 Ibraheem A, Olopade OI, Huo D. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base. Cancer. PMID 32521056 DOI: 10.1002/Cncr.32956  0.432
2020 O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, et al. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Research and Treatment. PMID 32378051 DOI: 10.1007/S10549-020-05603-8  0.449
2020 Huo D, Beaubier N, Jaskowiak N, Nanda R, Fleming G, Hattori M, Rajagopal PS, Ibraheem A, Copley B, Niu Q, Liu F, Sveen E, Yoshimatsu T, Khramtsova G, Zheng Y, et al. Abstract B123: Using eHealth and data science to dissect breast cancer heterogeneity in the Chicago Multi-Ethnic (ChiMEC) Breast Cancer Cohort Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-B123  0.462
2020 Huo D, Kang M, Saulsberry L, Hasan Y. Abstract P4-12-14: Has hypofractionated whole breast radiation therapy become standard of care in the United States? An updated report from national cancer database Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P4-12-14  0.376
2020 Hattori M, Huo D, Beaubier N, Rajagopal PS, Yoshimatsu T, Zheng Y, Sveen E, Khramtsova G, Liu F, Abboushi T, White K, Olopade O. Abstract P4-05-10: Comparative analysis of genomic landscape reveals heterogeneity in HER2-positive primary breast cancers and residual disease following neoadjuvant therapy Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-05-10  0.477
2020 Theiner S, Hu D, Huntsman S, Shieh Y, Fejerman L, Acerbi I, Sawyer SD, Kendall P, Zheng W, Huo D, Olopade OI, Haiman C, Kerlikowske K, Cummings S, John E, et al. Abstract P2-10-05: A breast cancer multi-racial/ethnic polygenic risk score for improved personalized breast cancer screening Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P2-10-05  0.454
2020 Adedokun B, Du Z, Gao G, Ahearn T, Lunetta KL, Zirpoli G, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-4613  0.431
2020 Jia G, Ping J, Yang Y, Sanderson M, Cai Q, Guo X, Blot WJ, Li B, Bandera EV, Bolla MK, García-Closas M, Easton DF, Fadden MK, Gu J, Huo D, et al. Abstract 28: Integrating genomic and transcriptomic data to identify genetic loci associated with breast cancer risk in women of African ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-28  0.434
2020 Du Z, Gao G, Adedokun B, Ahearn T, Lunetta KL, Zirpoli G, Troester M, Ruiz-Narváez EA, Haddad S, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, ... ... Huo D, et al. Abstract 2320: Evaluating a polygenic risk score for breast cancer in women of African ancestry Epidemiology. 80: 2320-2320. DOI: 10.1158/1538-7445.Am2020-2320  0.487
2019 Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Zhou AY, Yoshimatsu TF, Rodriguez A, Madduri RK, Foster IT, Sallam A, Olopade OI, Huo D. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Uganda and Cameroon Women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31871109 DOI: 10.1158/1055-9965.Epi-19-0506  0.467
2019 Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H, Yang L, Chen Y, Zhang X, Wang T, Chen J, Chen Z, Yu C, Huo D, Li L, et al. Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. European Journal of Epidemiology. PMID 31754945 DOI: 10.1007/S10654-019-00585-4  0.467
2019 Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, ... ... Huo D, et al. Two truncating variants in FANCC and breast cancer risk. Scientific Reports. 9: 12524. PMID 31467304 DOI: 10.1038/s41598-019-48804-y  0.373
2019 West AH, Knollman H, Dugan J, Hedeker D, Handorf EA, Nielsen SM, Bealin LC, Goldblatt LG, Willems H, Daly MB, Afghahi A, Olopade OI, Hulick PJ, Shagisultanova E, Huo D, et al. Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study. Cancer Medicine. PMID 31407530 DOI: 10.1002/Cam4.2471  0.406
2019 Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, ... ... Huo D, et al. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. PMID 31213659 DOI: 10.1038/S41416-019-0492-8  0.347
2019 Wang S, Pitt JJ, Zheng Y, Yoshimatsu TF, Gao G, Sanni A, Oluwasola O, Ajani M, Fitzgerald D, Odetunde A, Khramtsova G, Hurley I, Popoola A, Falusi A, Ogundiran T, ... ... Huo D, et al. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria. International Journal of Cancer. PMID 31173346 DOI: 10.1002/Ijc.32498  0.414
2019 Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, ... ... Huo D, et al. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Human Mutation. PMID 31112363 DOI: 10.1002/Humu.23804  0.361
2019 Kar SP, Brenner H, Giles GG, Huo D, Milne RL, Rennert G, Simard J, Zheng W, Burgess S, Pharoah PDP. Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk. International Journal of Epidemiology. PMID 30929013 DOI: 10.1093/Ije/Dyz047  0.38
2019 Kar SP, Andrulis IL, Brenner H, Burgess S, Chang-Claude J, Considine D, Dörk T, Evans DGR, Gago-Domínguez M, Giles GG, Hartman M, Huo D, Kaaks R, Li J, Lophatananon A, et al. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. European Journal of Epidemiology. PMID 30737679 DOI: 10.1007/S10654-019-00485-7  0.466
2019 Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, ... ... Huo D, et al. Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nature Communications. 10: 288. PMID 30643118 DOI: 10.1038/S41467-018-07886-4  0.345
2019 Hoffman J, Fejerman L, Hu D, Huntsman S, Li M, John EM, Torres-Mejia G, Kushi L, Ding YC, Weitzel J, Neuhausen SL, Lott P, Echeverry M, Carvajal-Carmona L, ... ... Huo D, et al. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas. Breast Cancer Research : Bcr. 21: 3. PMID 30642363 DOI: 10.1186/S13058-018-1085-9  0.457
2019 Odedina SO, Ajayi IO, Morhason-Bello IO, Babatundetuk A, Huo D, Olopade OI, Ojengbede OA. Influence of a Teaching Session on Breast Self-Examination and Adherence Among Pregnant and Lactating Women in Ibadan, Nigeria Journal of Global Oncology. 5: 9-9. DOI: 10.1200/Jgo.19.18000  0.428
2019 Li S, Huo D, Ojengbede O, Olopade O. Breast Cancer and the Environment: A Pilot Study of Nigerian Women Journal of Global Oncology. 5: 5-5. DOI: 10.1200/Jgo.19.14000  0.448
2019 Abdulkareem FB, Khramtsova G, Adedokun B, Rotimi O, Abudu K, Badmos K, Ibraheem AF, Khramtsov A, Sveen L, Hurley I, Masaya H, Huo D, Olopade OI. Colorectal cancer molecular subtypes by immunohistochemistry in a patient cohort from Nigeria. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E15145  0.348
2019 Hattori M, Rajagopal PS, Sveen L, Khramtsova G, Yoshimatsu T, Beaubier N, Barber M, Abboushi T, Fang L, Zheng Y, White K, Huo D, Olopade OI. Genomic profiling of residual tumor after neoadjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 37: e12106-e12106. DOI: 10.1200/Jco.2019.37.15_Suppl.E12106  0.453
2019 Rajagopal PS, Beaubier N, Hattori M, Sveen L, Khramtsova G, Abboushi T, Barber M, Liu F, Yoshimatsu T, Zheng Y, White K, Huo D, Olopade OI. Determining clinical relevance of genomic heterogeneity in an ethnically diverse cohort of newly diagnosed patients with breast cancer. Journal of Clinical Oncology. 37: 3084-3084. DOI: 10.1200/Jco.2019.37.15_Suppl.3084  0.445
2019 Ibraheem A, Olopade O, Huo D. Abstract P4-08-12: Comparative analyses of the prognostic value of oncotype and mammaprint using the National Cancer Database Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-08-12  0.483
2019 Neerukonda A, Olopade O, Huang E, Huo D. Abstract P1-08-05: Type 2 diabetes and survival outcomes among a multi-ethnic cohort of breast cancer patients Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-08-05  0.444
2019 Adedokun B, Odedina S, Ojengbede O, Ademola A, Ogundiran T, Huo D, Olopade O, Agwai I, Makumbi T, Ndom P, Gakwaya A. Abstract 624: A case control study of benign breast disease and breast cancer among indigenous African women Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-624  0.454
2019 Ansari-Pour N, Pitt JJ, Dentro S, Fitzgerald D, Zheng Y, Yoshimatsu TF, Rajagopal P, Gruber A, Sanni A, Oluwasola O, Ajani M, Odetunde A, Popoola A, Falusi A, Ogundiran T, ... ... Huo D, et al. Abstract LB-300: The life history of breast cancer in Nigerian women: Evidence for ethnic differences in tumor evolution based on whole-genome sequencing Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-300  0.483
2019 Hattori M, Khramtsova G, Sveen L, Yoshimatsu T, Huo D, Olopade OI. Abstract 4040: PD-L1 expression level and CD8+/FoxP3+T cell ratio in breast cancer and prognosis Cancer Research. 79: 4040-4040. DOI: 10.1158/1538-7445.Am2019-4040  0.382
2018 Titus L, Hatch EE, Drake KM, Parker SE, Hyer M, Palmer JR, Strohsnitter WC, Adam E, Herbst AL, Huo D, Hoover RN, Troisi R. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reproductive Toxicology (Elmsford, N.Y.). 84: 32-38. PMID 30594671 DOI: 10.1016/J.Reprotox.2018.12.008  0.311
2018 Ibraheem AF, Press DJ, Olopade OI, Huo D. Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy? Cancer. PMID 30387876 DOI: 10.1002/Cncr.31818  0.342
2018 Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, ... ... Huo D, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nature Communications. 9: 4181. PMID 30327465 DOI: 10.1038/S41467-018-06616-0  0.465
2018 Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Huo D, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132  0.316
2018 Odedina SO, Ajayi IO, Adeniji-Sofoluwe A, Morhason-Bello IO, Huo D, Olopade OI, Ojengbede OA. A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria. Bmc Women's Health. 18: 152. PMID 30231883 DOI: 10.1186/S12905-018-0647-4  0.45
2018 Guindalini RS, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova GF, ... ... Huo D, et al. Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30154229 DOI: 10.1158/1078-0432.Ccr-18-0200  0.45
2018 Zheng Y, Walsh T, Gulsuner S, Casadei S, Lee MK, Ogundiran TO, Ademola A, Falusi AG, Adebamowo CA, Oluwasola AO, Adeoye A, Odetunde A, Babalola CP, Ojengbede OA, Odedina S, ... ... Huo D, et al. Inherited Breast Cancer in Nigerian Women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018783977. PMID 30130155 DOI: 10.1200/Jco.2018.78.3977  0.505
2018 Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, ... ... Huo D, et al. Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785204. PMID 30113886 DOI: 10.1200/Jco.2018.78.5204  0.346
2018 Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone KE, John EM, Gammon MD, Daly MB, Terry MB, Buys SS, Huo D, Olopade OI, Genkinger JM, Whittemore AS, et al. Germline variation and breast cancer incidence: A gene-based association study and whole-genome prediction of early onset breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29898891 DOI: 10.1158/1055-9965.Epi-17-1185  0.475
2018 Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y. Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry. Molecular Carcinogenesis. PMID 29873413 DOI: 10.1002/Mc.22845  0.467
2018 Wang S, Ogundiran TO, Ademola A, Oluwasola OA, Adeoye AO, Sofoluwe A, Morhason-Bello I, Odedina SO, Agwai I, Adebamowo C, Obajimi M, Ojengbede O, Olopade OI, Huo D. Development of a Breast Cancer Risk Prediction Model for Women in Nigeria. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29678902 DOI: 10.1158/1055-9965.Epi-17-1128  0.443
2018 Huo D, Perou CM, Olopade OI. Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening-Reply. Jama Oncology. PMID 29543936 DOI: 10.1001/Jamaoncol.2017.5909  0.442
2018 Wang S, Qian F, Zheng Y, Ogundiran T, Ojengbede O, Zheng W, Blot W, Nathanson KL, Hennis A, Nemesure B, Ambs S, Olopade OI, Huo D. Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry. Breast Cancer Research and Treatment. PMID 29302764 DOI: 10.1007/S10549-017-4638-1  0.415
2018 Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Sallam A, Olopade O, Huo D. Prevalence and Spectrum of Breast Cancer Inherited Mutations in Uganda and Cameroon Women Journal of Global Oncology. 4. DOI: 10.1200/Jgo.18.60600  0.479
2018 Odedina SO, Ajayi IO, Morhason-Bello IO, Adeniji-Sofoluwe A, Huo D, Olopade OI, Ojengbede O. Profile of Women With Breast Disorders in Pregnancy and Lactation and Additional Investigation Uptake Journal of Global Oncology. 4. DOI: 10.1200/Jgo.18.10340  0.4
2018 Shang L, Jaskowiak NT, Hedeker D, Olopade OI, Huo D. Pre- and post-treatment body weight and prognosis in a multiethnic cohort of breast cancer patients. Journal of Clinical Oncology. 36: 1501-1501. DOI: 10.1200/Jco.2018.36.15_Suppl.1501  0.43
2018 Whitaker K, Guindalini R, Abe H, Sheeth D, Huo D, Hong S, Churpek J, Verp M, Obeid E, Zheng Y, Amico A, Yoshimatsu T, Olopade O. Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-02-10  0.487
2018 Whitaker K, Abe H, Sheth D, Huo D, Yoshimatsu T, Verp M, Zheng Y, Karczmar G, Guindalini R, Olopade O. Abstract P4-02-01: Recall rates during breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-02-01  0.402
2018 Wang S, Pitt JJ, Zheng Y, Yoshimatsu TF, Gao G, Riester M, Sanni A, Oluwasola O, Fitzgerald D, Ogundiran T, Babalola C, Popoola A, Falusi A, Winckler W, Obafunwa J, ... ... Huo D, et al. Abstract 287: Germline variants and somatic mutation signatures in breast cancer across populations of African and European ancestry Cancer Research. 78: 287-287. DOI: 10.1158/1538-7445.Am2018-287  0.445
2017 Press DJ, Miller ME, Liederbach E, Yao K, Huo D. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clinical & Experimental Metastasis. PMID 29288366 DOI: 10.1007/S10585-017-9871-9  0.44
2017 Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Huo D. Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29254938 DOI: 10.1158/1055-9965.Epi-17-0755  0.474
2017 Press DJ, Ibraheem A, Dolan ME, Goss KH, Conzen S, Huo D. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Breast Cancer Research and Treatment. PMID 29181717 DOI: 10.1007/S10549-017-4587-8  0.373
2017 Troisi R, Hatch EE, Titus L, Strohsnitter W, Gail MH, Huo D, Adam E, Robboy SJ, Hyer M, Hoover RN, Palmer JR. Prenatal diethylstilbestrol exposure and cancer risk in women. Environmental and Molecular Mutagenesis. PMID 29124779 DOI: 10.1002/Em.22155  0.397
2017 Troisi R, Titus L, Hatch EE, Palmer JR, Huo D, Strohsnitter WC, Adam E, Ricker W, Hyer M, Hoover RN. A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk. The Journal of Clinical Endocrinology and Metabolism. PMID 29069384 DOI: 10.1210/Jc.2017-01940  0.312
2017 Gao G, Pierce BL, Olopade OI, Im HK, Huo D. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer. Plos Genetics. 13: e1006727. PMID 28957356 DOI: 10.1371/Journal.Pgen.1006727  0.471
2017 Wang S, Huo D, Kupfer S, Alleyne D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y. Genetic variation in the Vitamin D related pathway and breast cancer risk in women of African ancestry in the Root Consortium. International Journal of Cancer. PMID 28891071 DOI: 10.1002/Ijc.31038  0.414
2017 Vanderpuye VDNK, Olopade OI, Huo D. Pilot Survey of Breast Cancer Management in Sub-Saharan Africa. Journal of Global Oncology. 3: 194-200. PMID 28717760 DOI: 10.1200/Jgo.2016.004945  0.408
2017 Murphy ME, Liu S, Yao S, Huo D, Liu Q, Dolfi SC, Hirshfield KM, Hong CC, Hu Q, Olshan AF, Ogundiran TO, Adebamowo C, Domchek SM, Nathanson KL, Nemesure B, et al. A functionally significant SNP in TP53 and breast cancer risk in African-American women. Npj Breast Cancer. 3: 5. PMID 28649645 DOI: 10.1038/s41523-017-0007-9  0.377
2017 Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y. Association of breast cancer risk and the mTOR pathway in women of African ancestry in "The Root" Consortium. Carcinogenesis. PMID 28582508 DOI: 10.1093/Carcin/Bgx055  0.494
2017 Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone K, John EM, Gammon MD, Daly M, Terry MB, Buys SS, Huo D, Olopade O, Genkinger JM, Jasmine F, et al. Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. Breast Cancer Research and Treatment. PMID 28503721 DOI: 10.1007/S10549-017-4287-4  0.459
2017 White MG, Applewhite MK, Kaplan EL, Angelos P, Huo D, Grogan RH. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer. Journal of the American College of Surgeons. PMID 28473189 DOI: 10.1016/J.Jamcollsurg.2017.02.017  0.324
2017 Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Troester M, Ru Y, Lichtenberg T, Sturtz LA, Shelley CS, Benz CC, et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. Jama Oncology. PMID 28472234 DOI: 10.1001/Jamaoncol.2017.0595  0.458
2017 Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Huo D, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935  0.433
2017 Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28377418 DOI: 10.1158/1055-9965.Epi-16-0567  0.434
2017 Daly B, Olopade OI, Hou N, Yao K, Winchester DJ, Huo D. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. Jama Oncology. PMID 28152150 DOI: 10.1001/Jamaoncol.2016.6380  0.399
2017 Hasan Y, Waller J, Yao K, Chmura SJ, Huo D. Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States. Breast Cancer Research and Treatment. PMID 28120272 DOI: 10.1007/S10549-017-4120-0  0.374
2017 Olopade OI, Nielsen S, Wang S, Bernhisel R, Brown K, Cox HC, Cummings S, Rosenthal ET, Saam J, Lancaster JM, Huo D. Ancestry-based differences in hereditary cancer genetic testing. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13107  0.392
2017 Lee KM, Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Zheng Y, Olopade OI. Association of breast cancer risk in women of African ancestry with genetic variants in the TET-related DNA demethylation pathway. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13015  0.418
2017 Aschebrook-Kilfoy B, Kibriya MG, Chiu BC, Huo D, List MA, Stepniak E, Sarwar G, Shams RA, Gopalakrishnan R, Beau MML, Ahsan H. Variation in screening rates in a multi-ethnic population-based study in Chicago. Journal of Clinical Oncology. 35: 1509-1509. DOI: 10.1200/Jco.2017.35.15_Suppl.1509  0.326
2017 Olopade O, Pitt J, Riester M, Odetunde A, Yoshimatsu T, Labrot E, Ademola A, Sanni A, Okedere B, Mahan S, Nwosu I, Leary R, Ajani M, Johnson R, Sveen E, ... ... Huo D, et al. Abstract PD8-05: Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Pd8-05  0.458
2017 Wang S, Qian F, Zheng Y, Ogundiran T, Ojengbede O, Zheng W, Blot W, Nathanson K, Hennis A, Nemesure B, Ambs S, Olopade O, Huo D. Abstract P5-09-02: Breast cancer risk prediction using a polygenic risk score in women of African ancestry: Findings from GWAS in breast cancer in the African diaspora Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-09-02  0.469
2017 Huo D, Hu H, Rhie S, Gamazon E, Cherniack A, Liu J, Yoshimatsu T, Pitt J, Hoadley K, Troester M, Ru Y, Lichtenberg T, Sturtz L, Shelley C, Mills G, et al. Abstract P1-05-11: Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in the cancer genome atlas Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-05-11  0.48
2017 Huo D, Anderson D, Herbst AL. Abstract 709: Incidence and mortality of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: 40 years of long-term follow-up Cancer Research. 77: 709-709. DOI: 10.1158/1538-7445.Am2017-709  0.348
2017 Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Huo D, Olopade OI. Abstract 1312: Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry in the ROOT Consortium Epidemiology. 77: 1312-1312. DOI: 10.1158/1538-7445.Am2017-1312  0.44
2016 Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, et al. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. Human Molecular Genetics. 25: 4835-4846. PMID 28171663 DOI: 10.1093/Hmg/Ddw305  0.492
2016 Han YJ, Zhang J, Zheng Y, Huo D, Olopade OI. Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer. Plos One. 11: e0165559. PMID 27806084 DOI: 10.1371/Journal.Pone.0165559  0.445
2016 Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D. Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine. 95: e4975. PMID 27749552 DOI: 10.1097/Md.0000000000004975  0.462
2016 Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, et al. Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer. Human Molecular Genetics. PMID 27594435 DOI: 10.1093/hmg/ddw305  0.394
2016 Samaeekia R, Adorno-Cruz V, Bockhorn J, Chang YF, Huang S, Prat A, Ha N, Kibria G, Huo D, Zheng H, Dalton R, Wang Y, Moskalenko G, Liu H. MicroRNA-206 inhibits stemness and metastasis of breast cancer by targeting MKL1/IL11 pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27435395 DOI: 10.1158/1078-0432.Ccr-16-0943  0.386
2016 Huo D, Clayton WM, Yoshimatsu TF, Chen J, Olopade OI. Identification of a circulating MicroRNA signature to distinguish recurrence in breast cancer patients. Oncotarget. PMID 27409424 DOI: 10.18632/Oncotarget.10485  0.402
2016 Qian F, Feng Y, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Blot W, Ambrosone CB, John EM, Bernstein L, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry. Human Genetics. PMID 27380242 DOI: 10.1007/S00439-016-1707-1  0.402
2016 Liu J, Gustafson P, Huo D. Bayesian adjustment for the misclassification in both dependent and independent variables with application to a breast cancer study. Statistics in Medicine. PMID 27238294 DOI: 10.1002/Sim.6996  0.456
2016 Guindalini RS, Song A, Fackenthal JD, Olopade OI, Huo D. Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect. Cancer. PMID 26992017 DOI: 10.1200/Jco.2014.32.15_Suppl.1550  0.468
2016 Olayiwola O, Ogundiran T, Hardeman A, Yoshimatsu T, Clayton W, Adeoye A, Ademola A, Ajani M, Khramtsova G, Grushko T, Huo D, Zheng Y, Parker J, Perou C, Olopade O. Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-04-05  0.462
2016 Olopade O, Odetunde A, Riester M, Yoshimatsu T, Labrot E, Ademola A, Sanni A, Okedere B, Mahan S, Nwosu I, Leary R, Ajani M, Johnson R, Sveen E, Zheng Y, ... ... Huo D, et al. Abstract P6-03-17: Genomic landscape of breast cancers from women of African ancestry across the diaspora Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-03-17  0.488
2016 Pitt JJ, Yoshimatsu TF, Zheng Y, Grundstad J, Tuteja J, Wang J, Odetunde A, Khramtsova G, Clayton W, Ademola A, Ogundiran TO, Adeniji-Sofoluwe AT, Obajimi M, Adeoye A, Babalola C, ... ... Huo D, et al. Abstract 4494: Whole genome sequencing reveals different patterns of mutational mechanisms in breast tumors between women of African and European descent Cancer Research. 76: 4494-4494. DOI: 10.1158/1538-7445.Am2016-4494  0.446
2016 Wang S, Ogundiran T, Ademola A, Olayiwola OA, Adeoye A, Adeniji-Sofoluwe A, Morhason-Bello I, Odedina S, Agwai I, Adebamowo C, Obajimi M, Ojengbede O, Olopade OI, Huo D. Abstract 2590: Development and validation of a breast cancer risk prediction model for black women: findings from the Nigerian breast cancer study: Table 1 Epidemiology. 76: 2590-2590. DOI: 10.1158/1538-7445.Am2016-2590  0.478
2016 Machini K, Ndom P, Huo D. Factors affecting the quality of life for women diagnosed with breast in Cameroon Annals of Global Health. 82: 538. DOI: 10.1016/J.Aogh.2016.04.453  0.352
2015 Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, Le Beau MM, Pritchard CC, Walsh T, King MC, Olopade OI, et al. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer. PMID 26641009 DOI: 10.1002/Cncr.29615  0.45
2015 Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, ... ... Huo D, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985  0.424
2015 Huo D, Hou N, Jaskowiak N, Winchester DJ, Winchester DP, Yao K. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Annals of Surgical Oncology. PMID 25820998 DOI: 10.1245/S10434-015-4528-X  0.403
2015 Sighoko D, Ogundiran T, Ademola A, Adebamowo C, Chen L, Odedina S, Anetor I, Ndom P, Gakwaya A, Ojengbede O, Huo D, Olopade OI. Breast cancer risk after full-term pregnancies among African women from Nigeria, Cameroon, and Uganda. Cancer. PMID 25781581 DOI: 10.1002/Cncr.29305  0.376
2015 Ricks PM, Hershow RC, Rahimian A, Huo D, Johnson W, Prachand N, Jimenez A, Wiebel W, Paul W. A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 19: 326-32. PMID 25686142 DOI: 10.5588/Ijtld.14.0471  0.727
2015 Xu J, Chen Y, Huo D, Khramtsov A, Khramtsova G, Zhang C, Goss KH, Olopade OI. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Molecular Carcinogenesis. PMID 25663530 DOI: 10.1002/Mc.22292  0.408
2015 Grimm WA, Messer JS, Murphy SF, Nero T, Lodolce JP, Weber CR, Logsdon MF, Bartulis S, Sylvester BE, Springer A, Dougherty U, Niewold TB, Kupfer SS, Ellis N, Huo D, et al. The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut. PMID 25645662 DOI: 10.1136/Gutjnl-2014-308735  0.372
2015 Baretta Z, Olopade OI, Huo D. Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers. Breast (Edinburgh, Scotland). 24: 131-6. PMID 25534718 DOI: 10.1016/J.Breast.2014.12.001  0.377
2015 Churpek JE, Walsh T, Zheng Y, Moton Z, Thornton AM, Lee MK, Casadei S, Watts A, Neistadt B, Churpek MM, Huo D, Zvosec C, Liu F, Niu Q, Marquez R, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Research and Treatment. 149: 31-9. PMID 25428789 DOI: 10.1007/S10549-014-3195-0  0.488
2015 O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Huo D, Fleming GF, Ingle JN, Mayer IA, Morrow PKH, Storniolo AM, Forero-Torres A, Poznak CHV, Merkel DE, Rosner GL, Olopade OI, et al. Clinical evaluation of germline polymorphisms (SNPs) associated with capecitabine (C) toxicity (tox) in metastatic breast cancer (MBC). Journal of Clinical Oncology. 33: 1049-1049. DOI: 10.1200/Jco.2015.33.15_Suppl.1049  0.316
2015 Huo D, Hasan Y, Yao K. Abstract P1-15-16: The utilization of hypofractionated breast radiotherapy in the United States between 2003 and 2011 Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-15-16  0.444
2015 Huo D, Clayton WM, Yoshimatsu TF, Chen J, Olopade OI. Abstract 3995: Breast cancer molecular subtypes are reflected in circulating microRNA profiles Cancer Research. 75: 3995-3995. DOI: 10.1158/1538-7445.Am2015-3995  0.415
2014 Hou N, Ndom P, Jombwe J, Ogundiran T, Ademola A, Morhason-Bello I, Ojengbede O, Gakwaya A, Huo D. An epidemiologic investigation of physical activity and breast cancer risk in Africa. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2748-56. PMID 25242052 DOI: 10.1158/1055-9965.Epi-14-0675  0.439
2014 Qian F, Ogundiran T, Hou N, Ndom P, Gakwaya A, Jombwe J, Morhason-Bello I, Adebamowo C, Ademola A, Ojengbede O, Olopade OI, Huo D. Alcohol consumption and breast cancer risk among women in three sub-Saharan African countries. Plos One. 9: e106908. PMID 25198723 DOI: 10.1371/Journal.Pone.0106908  0.412
2014 Feng Y, Stram DO, Rhie SK, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, ... ... Huo D, et al. A comprehensive examination of breast cancer risk loci in African American women. Human Molecular Genetics. 23: 5518-26. PMID 24852375 DOI: 10.1093/Hmg/Ddu252  0.485
2014 Sighoko D, Liu J, Hou N, Gustafson P, Huo D. Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification? The Oncologist. 19: 592-601. PMID 24807915 DOI: 10.1634/Theoncologist.2013-0427  0.411
2014 Yao K, Czechura T, Liederbach E, Winchester DJ, Pesce C, Shaikh A, Winchester DP, Huo D. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database. Annals of Surgical Oncology. 21: 3457-65. PMID 24806115 DOI: 10.1245/S10434-014-3717-3  0.405
2014 Li H, Giger ML, Sun C, Ponsukcharoen U, Huo D, Lan L, Olopade OI, Jamieson AR, Brown JB, Di Rienzo A. Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers. Medical Physics. 41: 031917. PMID 24593735 DOI: 10.1118/1.4865811  0.369
2014 Zheng Y, Huo D, Ogundiran TO, Falusi AG, Ojengbede O, Adebamowo C, Blot WJ, Zheng W, Cai Q, Signorello LB, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, Hennis AJM, et al. Abstract B11: Replication of previously identified breast cancer susceptibility loci in a breast cancer case-control study on women of African ancestry Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-B11  0.478
2014 Feng Y, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, ... ... Huo D, et al. Abstract 943: A comprehensive examination of breast cancer risk loci in African American women Cancer Research. 74: 943-943. DOI: 10.1158/1538-7445.Am2014-943  0.488
2013 Walsh T, Zheng Y, Casadei S, Thornton AM, Lee MK, Churpek M, Huo D, Zvosec C, Liu F, Niu Q, Zhang J, Fackenthal J, King MC, Olopade OI. Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next-generation sequencing. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: CRA1501. PMID 28136065 DOI: 10.1200/Jco.2013.31.15_Suppl.Cra1501  0.465
2013 Hou N, Huo D, Dignam JJ. Prevention of colorectal cancer and dietary management. Chinese Clinical Oncology. 2: 13. PMID 25841493 DOI: 10.3978/J.Issn.2304-3865.2013.04.03  0.338
2013 Yao K, Winchester DJ, Czechura T, Huo D. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002. Breast Cancer Research and Treatment. 142: 465-76. PMID 24218052 DOI: 10.1007/S10549-013-2745-1  0.394
2013 Oluwasola AO, Malaka D, Khramtsov AI, Ikpatt OF, Odetunde A, Adeyanju OO, Sveen WE, Falusi AG, Huo D, Olopade OI. Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution. Annals of Diagnostic Pathology. 17: 526-30. PMID 24095629 DOI: 10.1016/J.Anndiagpath.2013.07.003  0.379
2013 Hou N, Hong S, Wang W, Olopade OI, Dignam JJ, Huo D. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density. Journal of the National Cancer Institute. 105: 1365-72. PMID 24003037 DOI: 10.1093/Jnci/Djt207  0.491
2013 Czechura T, Winchester DJ, Pesce C, Huo D, Winchester DP, Yao K. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the national cancer data base. Annals of Surgical Oncology. 20: 3223-32. PMID 23975298 DOI: 10.1245/S10434-013-3154-8  0.449
2013 Pesce C, Czechura T, Winchester DJ, Huo D, Winchester DP, Yao K. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004-2010: a report from the National Cancer Data Base. Annals of Surgical Oncology. 20: 3259-65. PMID 23975297 DOI: 10.1245/S10434-013-3153-9  0.397
2013 Bhatta SS, Hou N, Moton ZN, Polite BN, Fleming GF, Olopade OI, Huo D, Hong S. Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer. Springerplus. 2: 356. PMID 23961419 DOI: 10.1186/2193-1801-2-356  0.454
2013 Hou N, Ogundiran T, Ojengbede O, Morhason-Bello I, Zheng Y, Fackenthal J, Adebamowo C, Anetor I, Akinleye S, Olopade OI, Huo D. Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study. Annals of Epidemiology. 23: 551-7. PMID 23880155 DOI: 10.1016/J.Annepidem.2013.06.008  0.442
2013 Hou N, Huo D. Incidence rate of breast cancer in young women. Jama. 309: 2433. PMID 23780447 DOI: 10.1001/Jama.2013.6456  0.466
2013 Wang PY, Huo D, Sun C, Olopade OI. The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo. European Journal of Clinical Pharmacology. 69: 1733-5. PMID 23740002 DOI: 10.1007/S00228-013-1538-0  0.321
2013 Davis MB, Liu X, Wang S, Reeves J, Khramtsov A, Huo D, Olopade OI. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity. Molecular Cancer. 12: 40. PMID 23663560 DOI: 10.1186/1476-4598-12-40  0.412
2013 Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Huo D, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212  0.453
2013 Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, ... ... Huo D, et al. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis. 34: 1520-8. PMID 23475944 DOI: 10.1093/Carcin/Bgt090  0.477
2013 Hou N, Huo D. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Research and Treatment. 138: 633-41. PMID 23446808 DOI: 10.1007/S10549-013-2434-0  0.468
2013 Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang YF, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Young Park S, Eileen Dolan M, Perou CM, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 Nature Communications. 4. PMID 23340433 DOI: 10.1038/Ncomms2393  0.397
2013 Bockhorn J, Yee K, Chang YF, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Breast Cancer Research and Treatment. 137: 373-382. PMID 23224145 DOI: 10.1007/S10549-012-2346-4  0.424
2013 Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. A genome-wide association study of breast cancer in women of African ancestry. Human Genetics. 132: 39-48. PMID 22923054 DOI: 10.1007/S00439-012-1214-Y  0.442
2013 Liu H, Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang Y, Huo D, Lu J, Dolan E, Perou CM, Olopade OI, Clarke MF, Greene G. Abstract 832: MicroRNA-30c inhibits human breast tumor chemo-resistance by regulating twinfinlin-1 (TWF1) and IL-11. Cancer Research. 73: 832-832. DOI: 10.1158/1538-7445.Am2013-832  0.38
2013 Bockhorn J, Yee K, Chang Y, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olufunmilayo OI, Clarke MF, Liu H, Greene G. Abstract 5337: MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Cancer Research. 73: 5337-5337. DOI: 10.1158/1538-7445.Am2013-5337  0.426
2013 Yoshimatsu TF, Yao K, Kaul K, Turk MA, Olopade OI, Huo D. Abstract 5332: MicroRNA profile of triple-negative breast cancer and prognosis. Cancer Research. 73: 5332-5332. DOI: 10.1158/1538-7445.Am2013-5332  0.362
2013 Xu J, Chen Y, Khramtsov A, Huo D, Goss K, Olopade OI. Abstract 3132: Beta-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Cancer Research. 73: 3132-3132. DOI: 10.1158/1538-7445.Am2013-3132  0.378
2013 Han Y, Zhang J, Zheng Y, Huo D, Olopade OI. Abstract 2565: Functional characterization of genetic variants at 16q12 associated with breast cancer in women of African ancestry. Cancer Research. 73: 2565-2565. DOI: 10.1158/1538-7445.Am2013-2565  0.475
2013 Hou N, Huo D. Abstract 143: Breast cancer incidence rate in american women started to increase: Trend analysis from 2000 to 2009. Cancer Research. 73: 143-143. DOI: 10.1158/1538-7445.Am2013-143  0.484
2013 Huo D, Czechura T, Winchester D, Winchester D, Yao K. Abstract P5-14-09: Brachytherapy, 3-dimentional conformal radiotherapy, and intensity modulated radiotherapy for breast cancer patients undergoing breast conservation: Effectiveness and guideline concordance Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-14-09  0.444
2013 Yao K, Tomasz C, Pesce C, Huo D, David W, David W, Edward W. Abstract P3-06-14: Increase in the proportion of stage IV breast cancer amongst young women with newly diagnosed breast cancer, report from the National cancer data base, 1998-2009 Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-06-14  0.426
2013 Sighoko D, Hou N, Ogundiran T, Adebamowo C, Ademola A, Ojengbede O, Anetor I, Akinleye S, Ndom P, Gakwaya A, Huo D, Olopade O. Abstract P3-06-13: Transient increase in breast cancer risk after a full term pregnancy among African women Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-06-13  0.398
2012 Zheng Y, Huo D, Zhang J, Yoshimatsu TF, Niu Q, Olopade OI. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women. Plos One. 7: e40494. PMID 22792352 DOI: 10.1371/Journal.Pone.0040494  0.468
2012 Zhang J, Fackenthal JD, Zheng Y, Huo D, Hou N, Niu Q, Zvosec C, Ogundiran TO, Hennis AJ, Leske MC, Nemesure B, Wu SY, Olopade OI. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Breast Cancer Research and Treatment. 134: 889-94. PMID 22739995 DOI: 10.1007/S10549-012-2136-Z  0.447
2012 Ogundiran TO, Huo D, Adenipekun A, Campbell O, Oyesegun R, Akang E, Adebamowo C, Olopade OI. Body fat distribution and breast cancer risk: Findings from the Nigerian breast cancer study Cancer Causes and Control. 23: 565-574. PMID 22367701 DOI: 10.1007/S10552-012-9916-Y  0.452
2012 Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, et al. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis. 33: 835-40. PMID 22357627 DOI: 10.1093/Carcin/Bgs093  0.424
2012 Ndom P, Um G, Bell EM, Eloundou A, Hossain NM, Huo D. A meta-analysis of male breast cancer in Africa. Breast (Edinburgh, Scotland). 21: 237-41. PMID 22300703 DOI: 10.1016/J.Breast.2012.01.004  0.432
2012 Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 136: 355-63. PMID 22245973 DOI: 10.1007/S10549-011-1910-7  0.423
2012 Hou N, Zheng Y, Gamazon ER, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, ... ... Huo D, et al. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 552-6. PMID 22237986 DOI: 10.1158/1055-9965.Epi-11-0979  0.471
2012 Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, ... ... Huo D, et al. Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Research and Treatment. 132: 341-5. PMID 22134622 DOI: 10.1007/S10549-011-1890-7  0.48
2012 Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling RV, Olugbile S, Polite BN, Olopade OI. Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 350-9. PMID 22114137 DOI: 10.1158/1078-0432.Ccr-11-1397  0.376
2012 Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, Nordgard SH, Grushko T, Huo D, Nwachukwu C, Nobel A, Kristensen VN, Børresen-Dale AL, Olopade OI, Perou CM. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Research and Treatment. 133: 865-80. PMID 22048815 DOI: 10.1007/S10549-011-1846-Y  0.387
2012 Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, Niu Q, Huo D, Sveen WE, Ogundiran T, Adebamowo C, Odetunde A, Falusi AG, Olopade OI. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. International Journal of Cancer. Journal International Du Cancer. 131: 1114-23. PMID 22034289 DOI: 10.1002/Ijc.27326  0.468
2012 Zheng Y, Zhang J, Niu Q, Huo D, Olopade OI. Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer. 118: 1362-70. PMID 21932393 DOI: 10.1002/Cncr.26388  0.461
2012 Sun C, Huo D, Nemesure B, Hennis A, Leske MC, Wu SY, Niu Q, Olopade OI, Di Rienzo A. Lack of association between common UGT2B nonsynonymous single-nucleotide polymorphisms and breast cancer in populations of African ancestry. International Journal of Cancer. Journal International Du Cancer. 130: 2740-2. PMID 21780111 DOI: 10.1002/Ijc.26300  0.334
2012 Sun C, Southard C, Huo D, Hernandez RD, Witonsky DB, Olopade OI, Di Rienzo A. SNP discovery, expression and cis-regulatory variation in the UGT2B genes. The Pharmacogenomics Journal. 12: 287-96. PMID 21358749 DOI: 10.1038/Tpj.2011.2  0.302
2012 Czechura T, Yao K, Huo D, Shaikh A, Winchester DP, Winchester DJ. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2002-2007: Report from the National Cancer Data Base. Journal of Clinical Oncology. 30: 6040-6040. DOI: 10.1200/Jco.2012.30.15_Suppl.6040  0.396
2012 Hou N, Yao K, Jaskowiak NT, Hasan Y, Winchester DJ, Winchester DP, Huo D. Patterns of regional node irradiation therapy following breast-conserving surgery: Report from the National Cancer Data Base 2003-2007. Journal of Clinical Oncology. 30: 1101-1101. DOI: 10.1200/Jco.2012.30.15_Suppl.1101  0.435
2012 Yao K, Czechura T, Huo D, Winchester DP, Edge SB, Winchester DJ. Utilization of post-lumpectomy radiation therapy in women 70 years of age or older: A report from the National Cancer Data Base. Journal of Clinical Oncology. 30: 1033-1033. DOI: 10.1200/Jco.2012.30.15_Suppl.1033  0.39
2012 Hou N, Gakwaya A, Ndom P, Ojengbede O, Olopade OI, Huo D. Abstract 674: A pilot study of physical activity and breast cancer risk in Africa Cancer Research. 72: 674-674. DOI: 10.1158/1538-7445.Am2012-674  0.42
2012 Huang S, Yee K, Bockhorn J, Kim S, Huo D, Olopade O, Liu H, Greene G. Abstract 4198: Transcriptional regulation of breast cancer microRNAs by GATA3 and TFAP2A Cancer Research. 72: 4198-4198. DOI: 10.1158/1538-7445.Am2012-4198  0.401
2012 Yoshimatsu TF, Zheng Y, Zhang J, Huo D, Olopade OI. Abstract 2620: Contribution of risk variant in miR-125b binding site of BMPR1B in women of African ancestry with breast cancer Cancer Research. 72: 2620-2620. DOI: 10.1158/1538-7445.Am2012-2620  0.451
2012 Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu S, Leske MC, Ambs S, Niu Q, Zhang J, ... ... Huo D, et al. Abstract 2606: Absence of association between common genetic polymorphisms in the TERT-CLPTM1L locus and breast cancer risk in women of African descent Cancer Research. 72: 2606-2606. DOI: 10.1158/1538-7445.Am2012-2606  0.451
2012 Khramtsova GF, Islam ABMMK, Khramtsov AI, Lyman P, Chuanhong L, Jene-Sanz A, Sveen WE, Huo D, Lopez-Bigas N, Benevolenskaya EV, Olopade OI. Abstract 1061: EZH2 expression in different subtypes of human breast cancer Cancer Research. 72: 1061-1061. DOI: 10.1158/1538-7445.Am2012-1061  0.428
2012 Miller ME, Kunnavakkam R, Khramtsova G, Khramtsov A, Sylvester B, Huo D, Olopade OI, Goss KH. Abstract B53: Analysis of Wnt signaling as a determinant of racial disparities in colorectal cancer outcomes. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B53  0.373
2012 Yao K, Du H, Tomasz C, Winchester DP, Winchester DJ, Hou N, Huo D. Abstract P4-14-06: Contralateral Prophylactic Mastectomy and Survival: Selection Bias or True Survival Benefit? Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-14-06  0.31
2012 Huo D. Abstract P2-10-21: Prognostic value of estrogen receptor status in women with synchronous or metachronous breast cancers Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-10-21  0.471
2011 Bhatta S, Hou N, Huo D, Polite BN, Fleming GF, Olopade OI, Hong S. Compliance to adjuvant hormone therapy for black and white women with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1555. PMID 28024043 DOI: 10.1200/Jco.2011.29.15_Suppl.1555  0.468
2011 Cappetta A, Nanda R, Liao C, Huo D, Chen LF, Artioli G, Zagonel V, Olopade OI. Adjuvant chemotherapy in American and Italian patients with BRCA1/2-associated breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1084. PMID 28021264 DOI: 10.1200/Jco.2011.29.15_Suppl.1084  0.479
2011 Chen Y, Xu J, Borowicz S, Collins C, Huo D, Olopade OI. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells. Bmc Cancer. 11: 246. PMID 21668996 DOI: 10.1186/1471-2407-11-246  0.35
2011 Sun C, Huo D, Southard C, Nemesure B, Hennis A, Cristina Leske M, Wu SY, Witonsky DB, Olopade OI, Di Rienzo A. A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk. Human Genetics. 130: 767-75. PMID 21660508 DOI: 10.1007/S00439-011-1025-6  0.429
2011 Zheng Y, Zhang J, Niu Q, Olopade OI, Huo D. Germline mutational analysis of the C19orf62 gene in African-American women with breast cancer. Breast Cancer Research and Treatment. 127: 871-7. PMID 21431873 DOI: 10.1007/S10549-011-1445-Y  0.484
2011 Huo D, Melkonian S, Rathouz PJ, Khramtsov A, Olopade OI. Concordance in histological and biological parameters between first and second primary breast cancers. Cancer. 117: 907-15. PMID 20945326 DOI: 10.1002/Cncr.25587  0.477
2011 Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, et al. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Research and Treatment. 128: 703-11. PMID 20842526 DOI: 10.1007/S10549-010-1154-Y  0.453
2011 Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, John EM, Hennis A, Nemesure B, Wu S, Ambs S, Niu Q, Zhang J, Cox NJ, et al. Abstract LB-425: Replication of 18 susceptibility loci of breast cancer in women of African ancestry Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-425  0.423
2011 Zheng Y, Huo D, Zhang J, Yoshimatsu TF, Niu Q, Olopade OI. Abstract 5604: Microsatellites in the estrogen (ESR1, ESR2) and androgen receptor (AR) genes and risk of breast cancer in women of African ancestry Cancer Research. 71: 5604-5604. DOI: 10.1158/1538-7445.Am2011-5604  0.488
2011 Khramtsova GF, Ward J, Khramtsov AI, Hope K, Sveen L, Wu S, Brewster K, Huo D, Nemesure B, Hennis AJM, Olopade OI. Abstract 5066: Molecular profiles of breast cancer in Barbados Cancer Research. 71: 5066-5066. DOI: 10.1158/1538-7445.Am2011-5066  0.457
2011 Hou N, Ogundiran TO, Adebamowo CA, Olopade OI, Huo D. Abstract 3734: Alcohol consumption and breast cancer risk among Nigerian women Cancer Research. 71: 3734-3734. DOI: 10.1158/1538-7445.Am2011-3734  0.436
2011 Hou N, Yao K, Winchester DJ, Jaskowiak N, Winchester DP, Huo D. Abstract A62: Secular trends and disparity of adjuvant hormone therapy use for ductal carcinoma in situ: National Cancer Database, 1998–2007 Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-A62  0.444
2010 Ogundiran TO, Huo D, Adenipekun A, Campbell O, Oyesegun R, Akang E, Adebamowo C, Olopade OI. Case-control study of body size and breast cancer risk in Nigerian women American Journal of Epidemiology. 172: 682-690. PMID 20716701 DOI: 10.1093/Aje/Kwq180  0.491
2010 Zheng Y, Zhang J, Hope K, Niu Q, Huo D, Olopade OI. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Research and Treatment. 124: 857-61. PMID 20697805 DOI: 10.1007/S10549-010-1095-5  0.442
2010 Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A, Jonasdottir A, Besenbacher S, Kostic JP, Fackenthal JD, Huo D, Adebamowo C, Ogundiran T, Olson JE, Fredericksen ZS, et al. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. Plos Genetics. 6: e1001029. PMID 20661439 DOI: 10.1371/Journal.Pgen.1001029  0.399
2010 Zhang J, Fackenthal JD, Huo D, Zheng Y, Olopade OI. Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population. Breast Cancer Research and Treatment. 124: 573-7. PMID 20596889 DOI: 10.1007/S10549-010-1006-9  0.43
2010 Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. The American Journal of Pathology. 176: 2911-20. PMID 20395444 DOI: 10.2353/Ajpath.2010.091125  0.427
2010 Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflammatory Bowel Diseases. 16: 1352-6. PMID 20027656 DOI: 10.1002/Ibd.21184  0.343
2010 Adeniji KA, Huo D, Khramtsov A, Zhang C, Olopade OI. Molecular profiles of breast cancer in Ilorin, Nigeria. Journal of Clinical Oncology. 28: 1602-1602. DOI: 10.1200/Jco.2010.28.15_Suppl.1602  0.439
2010 Grushko TA, Nwachukwu C, Charoenthammaraksa S, Huo D, Khramtsov A, Mashek H, Zhang C, Xu J, Perou CM, Olopade OI. Evaluation of BRCA1 inactivation by promoter methylation as a marker of triple-negative and basal-like breast cancers. Journal of Clinical Oncology. 28: 10510-10510. DOI: 10.1200/Jco.2010.28.15_Suppl.10510  0.415
2010 Nwachukwu C, Zhang C, Duan S, Huo D, Minn A, Perou C, Olopade O. Abstract 3004: Specific microRNAs associate with aggressive breast tumor phenotypes in an ethnically diverse patient cohort Cancer Research. 70: 3004-3004. DOI: 10.1158/1538-7445.Am10-3004  0.353
2010 Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling R, Polite B, Olopade OI. Abstract 28: Molecular analysis of colorectal cancer progression in an ethnically diverse cohort reveals a higher prevalence of KRAS mutations in African Americans Cancer Research. 70: 28-28. DOI: 10.1158/1538-7445.Am10-28  0.342
2010 Lubin GP, Khramtsov A, Khramtsova G, Sveen WE, Perou CM, Huo D, Olopade OI. Abstract 1176: αB-Crystallin expression across different stages and subtypes of breast cancer analyzed using tissue microarrays Cancer Research. 70: 1176-1176. DOI: 10.1158/1538-7445.Am10-1176  0.466
2010 Adeyanju O, Khramtsov A, Verma A, Liu L, Wang X, Sattar H, Olopade O, Huo D. Abstract P6-01-06: Identification of Molecular Subtypes of DCIS and Invasive Breast Cancer Using Computerized Image Analysis for Data Integration Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-01-06  0.424
2010 Sun C, Huo D, Nemesure B, Hennis A, Witonsky D, Niu Q, Rienzo AD, Olopade O. Abstract P3-12-07: Polymorphisms in the UDP-Glucuronosyltransferase 2B Gene Family and Risk of Breast Cancer in Women of African Descent Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-12-07  0.428
2010 Huo D, Hou N, Ogundiran T, Olopade O. Abstract P3-11-10: Risk Factors for Pregnancy-Associated Breast Cancer: A Report from the Nigerian Breast Cancer Study Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-11-10  0.484
2009 Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4515-21. PMID 19704069 DOI: 10.1200/Jco.2008.19.6873  0.453
2009 Huo D, Hetzel JT, Roy H, Rubin DT. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1979-85. PMID 19531678 DOI: 10.1158/1055-9965.Epi-09-0241  0.355
2009 Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI. Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1184-90. PMID 19188678 DOI: 10.1200/Jco.2008.17.5869  0.308
2009 Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry. Familial Cancer. 8: 15-22. PMID 18679828 DOI: 10.1007/S10689-008-9205-9  0.41
2009 Cerri E, Spyrka S, Huo D, Khramtsov A, Khramtsova G, Olopade O, Innocenti F, Nanda R. The role of VEGFR-2 genetic variation in breast cancer progression. Cancer Research. 69: 904. DOI: 10.1158/0008-5472.Sabcs-904  0.368
2009 Malaka D, Khramtsov A, Oluwasola O, Odetunde A, Falusi A, Grushko T, Huo D, Olopade O. Validation of breast cancer biomarkers between a field immunohistochemistry laboratory in Nigeria and its US-based counterpart. Cancer Research. 69: 4039. DOI: 10.1158/0008-5472.Sabcs-4039  0.447
2009 Huo D, Melkonian S, Rathouz P, Khramtsov A, Olopade O. Concordance in Hormone Receptor Status between First and Second Breast Cancers. Cancer Research. 69: 4144-4144. DOI: 10.1158/0008-5472.Sabcs-09-4144  0.492
2009 Rajagopal P, Fackenthal J, Huo D, Niu Q, Zhang J, Kirchhoff T, Offit K, Olopade O. Genetic Risks for Breast Cancer in African American Women: Analysis of Candidate Single Nucleotide Polymorphisms from Association Studies. Cancer Research. 69: 3068-3068. DOI: 10.1158/0008-5472.Sabcs-09-3068  0.482
2009 Tonlaar N, Campbell M, Garwood E, Khramtsov A, Moore D, Au A, Baehner F, Huo D, David M, Oluwasola O, Odetunde A, Tretiakova M, Li S, Gong C, Tonner E, et al. Association of Proliferating Macrophages with High Grade, Hormone Receptor Negative Breast Cancer. Cancer Research. 69: 3042-3042. DOI: 10.1158/0008-5472.Sabcs-09-3042  0.424
2009 Khramtsova G, Liao C, Khramtsov A, Li S, Gong C, Huo D, Nanda R. The M2/Alternatively Activated Macrophage Phenotype Correlates with Aggressive Histopathologic Features and Poor Clinical Outcome in Early Stage Breast Cancer. Cancer Research. 69: 107-107. DOI: 10.1158/0008-5472.Sabcs-09-107  0.391
2008 Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: pathways to personalized medicine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7988-99. PMID 19088015 DOI: 10.1158/1078-0432.Ccr-08-1211  0.498
2008 Calderwood AH, Huo D, Rubin DT. Association between colorectal cancer and urologic cancers. Archives of Internal Medicine. 168: 1003-9. PMID 18474765 DOI: 10.1001/Archinte.168.9.1003  0.392
2008 Huo D, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa F, Ahsan H, Olopade OI. Parity and breastfeeding are protective against breast cancer in Nigerian women. British Journal of Cancer. 98: 992-6. PMID 18301401 DOI: 10.1038/Sj.Bjc.6604275  0.489
2008 Garner CP, Ding YC, John EM, Ingles SA, Olopade OI, Huo D, Adebamowo C, Ogundiran T, Neuhausen SL. Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent. Human Genetics. 123: 247-55. PMID 18210156 DOI: 10.1007/S00439-008-0468-X  0.486
2008 Lauderdale DS, Huo D. Cancer death rates for older Asian-Americans: classification by race versus ethnicity. Cancer Causes & Control : Ccc. 19: 135-46. PMID 17992577 DOI: 10.1007/S10552-007-9079-4  0.361
2008 Huo D, Kim HJ, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Niu Q, Sveen L, Fackenthal JD, Fackenthal DL, Das S, Cox N, Di Rienzo A, Olopade OI. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans. Breast Cancer Research and Treatment. 110: 367-76. PMID 17909964 DOI: 10.1007/S10549-007-9720-7  0.459
2008 Ogundiran TO, Huo D, Adebamowo CA, Adenipekun AA, Campbell OB, Olopade OI. Case-control study of height, weight and BMI and breast cancer risk in Nigerian women Journal of Clinical Oncology. 26: 1506-1506. DOI: 10.1200/Jco.2008.26.15_Suppl.1506  0.434
2008 Huo D, Olopade OI. Abstract 3839: Is recent decline in breast cancer incidence equal across different US racial groups? Epidemiology. DOI: 10.1158/1538-7445.Am2008-3839  0.444
2008 Nourani S, Huo D, Strum W, Rubin DT. W1229 5-ASA Therapy and a Lower Inflammatory Score in Chronic Ulcerative Colitis Are Associated with a Decreased Risk of Dysplasia and Colorectal Cancer Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)63080-2  0.319
2007 Huo D, Olopade OI. Genetic testing in diverse populations: are researchers doing enough to get out the correct message? Jama. 298: 2910-1. PMID 18159061 DOI: 10.1001/Jama.298.24.2910  0.442
2007 Matthews AK, Sellergren SA, Huo D, List M, Fleming G. Complementary and Alternative Medicine Use Among Breast Cancer Survivors Journal of Alternative and Complementary Medicine. 13: 555-562. PMID 17604560 DOI: 10.1089/Acm.2007.03-9040  0.46
2007 Nanda R, Huo D, Cook M, Chen L, Hope K, Cummings S, Olopade OI. Outcomes after breast cancer in an ethnically diverse cohort of high-risk patients: Differences in survival based on BRCA1/BRCA2 mutation status Journal of Clinical Oncology. 25: 21116-21116. DOI: 10.1200/Jco.2007.25.18_Suppl.21116  0.484
2007 Collins C, Huo D, Xu J, Bleibel WK, Dolan ME, Olopade OI, Nanda R. Relationship between BRCA1 promoter methylation and sensitivity of breast cancer cell lines to cisplatin and paclitaxel Journal of Clinical Oncology. 25: 21083-21083. DOI: 10.1200/Jco.2007.25.18_Suppl.21083  0.395
2007 Huo D, Senie RT, Terry MB, Daly MB, Buys SS, Olopade OI. BRCA1 and BRCA2 mutation carrier predictions using the BRCAPRO model in clinic-based minority families enrolled in the Breast Cancer Family Registry (B-CFR) Journal of Clinical Oncology. 25: 21037-21037. DOI: 10.1200/Jco.2007.25.18_Suppl.21037  0.314
2006 Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Aminosalicylate Therapy in the Prevention of Dysplasia and Colorectal Cancer in Ulcerative Colitis Clinical Gastroenterology and Hepatology. 4: 1346-1350. PMID 17059900 DOI: 10.1016/J.Cgh.2006.08.014  0.313
2006 Jin JO, Lehmann J, Taxy J, Huo D, Stöckle M, Vogelzang NJ, Steinberg G, Stadler WM. Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer. Clinical Genitourinary Cancer. 5: 150-154. PMID 17026804 DOI: 10.3816/Cgc.2006.N.032  0.345
2006 Hickson JA, Huo D, Vander Griend DJ, Lin A, Rinker-Schaeffer CW, Yamada SD. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma Cancer Research. 66: 2264-2270. PMID 16489030 DOI: 10.1158/0008-5472.Can-05-3676  0.325
2006 Stenson KM, Huo D, Blair E, Cohen EEW, Argiris A, Haraf DJ, Vokes EE. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope. 116: 33-36. PMID 16481805 DOI: 10.1097/01.Mlg.0000185846.27617.Fe  0.308
2005 Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 17: 170-84. PMID 15899754 DOI: 10.1521/Aeap.17.3.170.62900  0.564
2005 Hong AL, Kim HJ, Niu Q, Cummings SA, Huo D, Olopade OI. 5 Association Of Ugt1A1 Polymorphism And Bilirubin Levels In Female Multi-Racial/Ethnic Cohort Journal of Investigative Medicine. 53. DOI: 10.2310/6650.2005.00206.4  0.343
2005 Rubin DT, Gandhi R, Yadron N, Wood G, Huo D. Improving Knowledge of Familial Colorectal Cancer Risk Using the ACG Brochure: 1085 The American Journal of Gastroenterology. 100. DOI: 10.14309/00000434-200509001-01085  0.326
2004 Li LS, Huo D, Karrison T, Larson RA, Olopade O. Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? . Blood. 104: 2018-2018. DOI: 10.1182/Blood.V104.11.2018.2018  0.445
2003 Stadler WM, Huo D, George C, Yang X, Ryan CW, Karrison T, Zimmerman TM, Vogelzang NJ. Prognostic Factors for Survival With Gemcitabine Plus 5-fluorouracil Based Regimens for Metastatic Renal Cancer The Journal of Urology. 170: 1141-1145. PMID 14501711 DOI: 10.1097/01.Ju.0000086829.74971.4A  0.333
2003 Rubin DT, Djordjevic A, Huo D, Yadron N, Hanauer SB. Use of 5-ASA is associated with decreased risk of dysplasia and colon cancer (CRC) in ulcerative colitis (UC) Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)80178-6  0.343
2003 Rubin DT, Huo D, Calderwood AH. Risk for colorectal cancer after a urologic malignancy The American Journal of Gastroenterology. 98. DOI: 10.1016/S0002-9270(03)01137-7  0.358
Show low-probability matches.